Press releases and news articles
Medical Ethics in the Media
Press releases
September 24, 2018
Prestigious grant to help fast-track new pain mitigation delivery via livestock feed supplements
New collaboration to advance animal wellbeing Leader in animal wellbeing solutions, Medical Ethics Pty Ltd, and animal nutrition provider, 4 Season Company, have established a new collaboration to trial pain mitigation technologies via a unique feed supplement. The research and development studies will involve incorporating a pain relief agent that is similar to human over-the-counter …
August 20, 2018
Medical Ethics appoints leading British Army surgeon to its Advisory Board
Lieutenant Colonel Steven Jeffery, Consultant Burns and Plastic Surgeon, to help guide the strategy for the development of the Group’s technology in humans for military application Melbourne, Australia – 20 August 2018 – Medical Ethics Pty Ltd (“Medical Ethics” or “the Group”), a commercial and development company focused on pain mitigation in wounds for humans …
Continue reading "Medical Ethics appoints leading British Army surgeon to its Advisory Board"
July 26, 2018
Medical Ethics selects Bayer as New Zealand commercial partner for Tri-Solfen®
Second country launch for Tri-Solfen®, which is already marketed by Bayer in Australia An important milestone as the Group continues to expand its international reach and to help minimise suffering associated with wounds Melbourne, Australia Medical Ethics Pty Ltd (“Medical Ethics” or “the Group”), a commercial and development company focused on pain mitigation in wounds …
Continue reading "Medical Ethics selects Bayer as New Zealand commercial partner for Tri-Solfen®"
July 9, 2018
Australian beef and dairy industry welcomes new registrations for Tri-Solfen®
Patented pain relief product for animal husbandry procedures is marketed by Bayer in Australia Expands Tri-Solfen’s® commercial potential Dossier submitted to the EMA for registration of Tri-Solfen® in Europe Melbourne, Australia – 9 July 2018 – Medical Ethics Pty Ltd (“Medical Ethics” or “the Group”), a commercial research and development company focused on pain …
Continue reading "Australian beef and dairy industry welcomes new registrations for Tri-Solfen®"
News articles
November 3, 2022
Livestock pain relief demand continues to grow
By Mark Phelps Updated November 1 2022 - 11:43am, first published 11:00am CLAIMS that only limited numbers of Australian livestock producers are using pain relief as part of routine surgical procedures including castration and dehorning have been refuted by industry heavyweights. Allan Giffard, one of the founders of popular off-the-shelf product Tri-Solfen, said the demand …
Continue reading "Livestock pain relief demand continues to grow"
June 16, 2022
Tri-Solfen® delivers FMD cure
Full article by Mark Phelps in Queensland Country Life Popular over-the-counter pain relief product Tri-Solfen® has emerged as an effective treatment for foot and mouth disease. Writing on the Research Outreach website, Professor Emeritus Peter Windsor and his team at the University of Sydney said Tri-Solfen® may be an inexpensive and effective solution to treat …
June 1, 2022
Tri-Solfen® ‘effective treatment’ for foot and mouth disease
By Mark Phelps June 1 2022 - 1:00pm POPULAR over-the-counter pain relief product Tri-Solfen has emerged as an effective treatment for foot and mouth disease. Writing on the Research Outreach website, Professor Emeritus Peter Windsor and his team at the University of Sydney said Tri-Solfen may be an inexpensive and effective solution to treat FMD, instead …
Continue reading "Tri-Solfen® ‘effective treatment’ for foot and mouth disease"
May 31, 2022
Promising results with a new treatment for Foot-and-Mouth disease
The original article can be found here on the Research Outreach site. Foot-and-Mouth disease (FMD) is a viral disease that affects many farm animals, including cattle, buffalo and small ruminants. In many developing countries, farmers often don’t have access to preventative treatments, and outbreaks are common. Professor Emeritus Peter Windsor and his team at the …
Continue reading "Promising results with a new treatment for Foot-and-Mouth disease"